DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18-Reference-Cited by-同舟云学术

DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18

Published:2022-10-30 Issue:1 Volume:23 Page:1-14
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Gan Hairun¹²³^ORCID,Li Luting¹²³^ORCID,Hu Xinyan¹²³^ORCID,Cai Jianxun¹²³,Hu Xiaojun¹,Zhang Haopei¹²³^ORCID,Zhao Ni¹,Xu Xiwei⁴^ORCID,Guo Hui¹^ORCID,Pang Pengfei¹²³^ORCID

Affiliation:

1. Center for Interventional Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China

2. Guangdong Provincial Key Laboratory of Biomedical Imaging, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China

3. Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, China

4. The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, China

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2022.2135960

Reference33 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma

3. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma

4. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis

5. Making sorafenib irresistible:In vivoscreening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy;Molecules;2023-04-30